|
|
Name: |
RA CAPITAL MANAGEMENT LLC |
City: |
BOSTON |
State: |
MA |
Zip: |
02199 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
99 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
ASND |
Ascendis Pharma AS |
1 |
- |
$172.22 |
$1,602,474,000 |
10,281,496 |
26.76% |
210,253,000 |
168,752 |
15.909 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
2 |
- |
$0.00 |
$460,262,000 |
12,189,149 |
7.69% |
-251,035,000 |
3,499,959 |
8.93 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
3 |
- |
$62.73 |
$322,291,000 |
6,084,412 |
5.38% |
-18,314,000 |
0 |
8.578 |
N/A |
|
JANX |
Janux Therapeutics, Inc. |
4 |
- |
$0.00 |
$302,122,000 |
11,189,693 |
5.05% |
-252,855,000 |
824,041 |
21.453 |
N/A |
|
NAMS |
Newamsterdam Pharma Ord Shs |
5 |
- |
$0.00 |
$207,544,000 |
10,138,938 |
3.47% |
-19,773,000 |
1,293,938 |
12.431 |
N/A |
|
ACLX |
Arcellx, Inc. |
6 |
- |
$0.00 |
$199,196,000 |
3,036,527 |
3.33% |
-14,564,000 |
249,200 |
5.648 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
7 |
- |
$13.17 |
$196,000,000 |
8,909,091 |
3.27% |
-41,873,000 |
0 |
8.637 |
N/A |
|
RNA |
Avidity Biosciences, Inc. |
8 |
- |
$29.03 |
$185,988,000 |
6,300,408 |
3.11% |
2,772,000 |
0 |
4.667 |
N/A |
|
WVE |
Wave Life Sciences Ltd. |
9 |
- |
$6.67 |
$147,072,000 |
18,202,009 |
2.46% |
-78,087,000 |
0 |
15.278 |
N/A |
|
ETNB |
89bio, Inc. |
10 |
- |
$9.86 |
$144,598,000 |
19,889,683 |
2.41% |
33,746,000 |
5,714,285 |
18.78 |
N/A |
|
SBTX |
Silverback Therapeutics, Inc. |
11 |
- |
$0.00 |
$136,631,000 |
10,860,977 |
2.28% |
22,048,000 |
0 |
6.273 |
N/A |
|
SION |
Sionna Therapeutics, Inc. |
12 |
New |
$0.00 |
$109,258,000 |
10,445,322 |
1.82% |
109,258,000 |
10,445,322 |
23.691 |
N/A |
|
LENZ |
Lenz Therapeutics |
13 |
- |
$30.18 |
$107,438,000 |
4,178,823 |
1.79% |
-13,205,000 |
0 |
16.366 |
N/A |
|
DYN |
Dyne Therapeutics, Inc. |
14 |
- |
$9.57 |
$101,613,000 |
9,714,392 |
1.7% |
-48,727,000 |
3,333,248 |
8.418 |
N/A |
|
TYRA |
Tyra Biosciences, Inc. |
15 |
- |
$0.00 |
$98,927,000 |
10,637,290 |
1.65% |
-48,931,000 |
0 |
20.169 |
N/A |
|
MLYS |
Mineralys Therapeutics, Inc. |
16 |
- |
$0.00 |
$97,619,000 |
6,147,280 |
1.63% |
37,903,000 |
1,296,296 |
12.361 |
N/A |
|
GERN |
Geron Corporation |
17 |
- |
$1.49 |
$96,003,000 |
60,379,366 |
1.6% |
-10,231,000 |
30,369,830 |
11.118 |
Drug Manufacturers - ... |
|
RXST |
Rxsight, Inc. |
18 |
- |
$12.67 |
$94,511,000 |
3,743,018 |
1.58% |
-34,174,000 |
0 |
10.438 |
N/A |
|
BCAX |
Bicara Therapeutics Inc. |
19 |
- |
$8.71 |
$90,637,000 |
6,955,993 |
1.51% |
-30,536,000 |
0 |
12.789 |
N/A |
|
IRON |
Disc Medicine, Inc |
20 |
New |
$54.50 |
$78,288,000 |
1,577,106 |
1.31% |
78,288,000 |
1,577,106 |
5.305 |
N/A |
|
GHRS |
Gh Research Ord Shs |
21 |
- |
$0.00 |
$76,599,000 |
6,944,648 |
1.28% |
29,792,000 |
257,959 |
14.216 |
N/A |
|
APGE |
Apogee Therapeutics, Inc. |
22 |
- |
$43.38 |
$58,636,000 |
1,569,491 |
0.98% |
-12,462,000 |
0 |
2.683 |
N/A |
|
DNTH |
Dianthus Therapeutics Ord Shs |
23 |
- |
$0.70 |
$52,003,000 |
2,866,733 |
0.87% |
11,315,000 |
1,000,333 |
8.821 |
N/A |
|
ZLAB |
Zai Lab Ltd |
24 |
- |
$34.74 |
$46,803,000 |
1,295,040 |
0.78% |
12,886,000 |
0 |
1.471 |
N/A |
|
DAWN |
Day One Biopharmaceuticals,... |
25 |
- |
$0.00 |
$45,642,000 |
5,755,577 |
0.76% |
-27,281,000 |
0 |
5.756 |
N/A |
|
SEPN |
Septerna, Inc. |
26 |
- |
$10.51 |
$40,506,000 |
6,995,858 |
0.68% |
-119,699,000 |
0 |
15.756 |
N/A |
|
TRML |
Tourmaline Bio |
27 |
- |
$0.00 |
$38,617,000 |
2,538,925 |
0.64% |
-12,872,000 |
0 |
6.146 |
N/A |
|
ELYM |
Eliem Therapeutics, Inc. |
28 |
- |
$0.00 |
$38,332,000 |
31,419,267 |
0.64% |
-18,223,000 |
0 |
46.853 |
N/A |
|
SRRK |
Scholar Rock Holding Corp |
29 |
- |
$35.81 |
$36,537,000 |
1,136,453 |
0.61% |
35,776,000 |
1,118,837 |
1.313 |
N/A |
|
URGN |
Urogen Pharma Ltd. |
30 |
New |
$13.49 |
$35,461,000 |
3,206,271 |
0.59% |
35,461,000 |
3,206,271 |
7.614 |
N/A |
|
ARTV |
Artiva Biotherapeutics, Inc. |
31 |
- |
$0.00 |
$29,560,000 |
9,853,302 |
0.49% |
-69,761,000 |
0 |
40.557 |
N/A |
|
FULC |
Fulcrum Therapeutics, Inc. |
32 |
- |
$0.00 |
$29,460,000 |
10,229,099 |
0.49% |
-18,617,000 |
0 |
10.819 |
N/A |
|
VOR |
Vor Biopharma Inc. |
33 |
- |
$0.00 |
$28,446,000 |
39,646,039 |
0.48% |
-15,561,000 |
0 |
60.39 |
N/A |
|
ATXS |
Astria Therapeutics, Inc |
34 |
- |
$5.57 |
$27,262,000 |
5,105,213 |
0.46% |
-18,379,000 |
0 |
8.616 |
N/A |
|
KURA |
Kura Oncology Inc |
35 |
- |
$5.67 |
$26,430,000 |
4,004,610 |
0.44% |
-12,339,000 |
-446,431 |
4.781 |
N/A |
|
GPCR |
Structure Therapeutics Inc. |
36 |
- |
$21.08 |
$26,267,000 |
1,517,418 |
0.44% |
-14,885,000 |
0 |
2.409 |
N/A |
|
CDTX |
Cidara Therapeutics, Inc. |
37 |
- |
$49.45 |
$23,539,000 |
1,092,796 |
0.39% |
-5,835,000 |
0 |
23.96 |
N/A |
|
JBIO |
Jade Biosciences |
38 |
- |
$0.00 |
$23,072,000 |
9,192,092 |
0.39% |
-1,287,000 |
0 |
33.22 |
N/A |
|
IDYA |
Ideaya Biosciences, Inc. |
39 |
- |
$0.00 |
$22,068,000 |
1,347,252 |
0.37% |
-12,556,000 |
0 |
1.382 |
N/A |
|
ITOS |
Iteos Therapeutics, Inc. |
40 |
- |
$0.00 |
$21,785,000 |
3,649,057 |
0.36% |
5,716,000 |
1,556,798 |
9.613 |
N/A |
|
TVTX |
Travere Therapeutics, Inc |
41 |
- |
$14.77 |
$20,608,000 |
1,150,000 |
0.34% |
575,000 |
0 |
1.283 |
N/A |
|
NKTX |
Nkarta, Inc. |
42 |
- |
$0.00 |
$19,881,000 |
10,805,129 |
0.33% |
-7,024,000 |
0 |
15.313 |
N/A |
|
GKOS |
Glaukos Corp |
43 |
New |
$101.42 |
$18,725,000 |
190,256 |
0.31% |
18,725,000 |
190,256 |
0.346 |
N/A |
|
MNPR |
Monopar Therapeutics |
44 |
- |
$33.60 |
$18,613,000 |
511,207 |
0.31% |
7,366,000 |
0 |
9.682 |
Biotechnology |
|
MTSR |
Metsera, Inc. |
45 |
New |
$28.59 |
$18,388,000 |
675,525 |
0.31% |
18,388,000 |
675,525 |
0.643 |
N/A |
|
EYPT |
EyePoint Pharmaceuticals Inc |
46 |
- |
$0.44 |
$17,245,000 |
3,181,818 |
0.29% |
-6,460,000 |
0 |
2.217 |
Biotechnology |
|
TXG |
10x Genomics, Inc. |
47 |
- |
$0.00 |
$16,973,000 |
1,944,247 |
0.28% |
-30,119,000 |
-1,335,154 |
1.85 |
N/A |
|
ACRV |
Acrivon Therapeutics, Inc. |
48 |
- |
$1.20 |
$16,931,000 |
8,340,508 |
0.28% |
-33,279,000 |
0 |
26.931 |
N/A |
|
ELVN |
Enliven Therapeutics Ord Shs |
49 |
- |
$0.00 |
$16,708,000 |
848,986 |
0.28% |
-2,394,000 |
0 |
1.69 |
N/A |
|
ABOS |
Acumen Pharmaceuticals, Inc. |
50 |
- |
$0.00 |
$16,425,000 |
14,932,063 |
0.27% |
-9,258,000 |
0 |
24.854 |
N/A |
|
SLDB |
Solid Biosciences Inc |
51 |
- |
$4.72 |
$16,023,000 |
4,330,446 |
0.27% |
-1,299,000 |
0 |
11.219 |
N/A |
|
NRIX |
Nurix Therapeutics, Inc. |
53 |
- |
$0.00 |
$15,840,000 |
1,333,333 |
0.26% |
-9,280,000 |
0 |
0 |
N/A |
|
CBLL |
Ceribell, Inc. |
52 |
- |
$18.90 |
$15,840,000 |
824,582 |
0.26% |
-5,500,000 |
0 |
4.18 |
N/A |
|
INSM |
Insmed Inc |
54 |
- |
$99.49 |
$15,258,000 |
200,000 |
0.25% |
1,450,000 |
0 |
0.105 |
Biotechnology |
|
TSHA |
Taysha Gene Therapies, Inc. |
55 |
- |
$0.00 |
$15,113,000 |
10,872,503 |
0.25% |
-3,696,000 |
0 |
5.815 |
N/A |
|
PEPG |
Pepgen Inc. |
56 |
- |
$1.15 |
$15,019,000 |
10,689,545 |
0.25% |
-25,494,000 |
0 |
32.8 |
N/A |
|
FDMT |
4d Molecular Therapeutics Inc. |
57 |
- |
$0.00 |
$14,739,000 |
4,563,211 |
0.25% |
-10,678,000 |
0 |
7.34 |
N/A |
|
TARA |
Protara Therapeutics, Inc |
58 |
- |
$2.88 |
$14,484,000 |
3,400,000 |
0.24% |
-3,468,000 |
0 |
32.35 |
N/A |
|
LRMR |
Larimar Therapeutics Inc |
59 |
- |
$1.15 |
$12,998,000 |
6,045,351 |
0.22% |
-10,398,000 |
0 |
9.049 |
N/A |
|
ELDN |
Eledon Pharmaceuticals Ord Shs |
60 |
- |
$2.69 |
$12,090,000 |
3,566,338 |
0.2% |
-2,603,000 |
0 |
8.992 |
N/A |
|
ALEC |
Alector, Inc. |
61 |
- |
$1.48 |
$11,925,000 |
9,695,228 |
0.2% |
-6,399,000 |
0 |
12.235 |
N/A |
|
SERA |
Sera Prognostics, Inc. |
62 |
- |
$4.09 |
$11,161,000 |
3,032,808 |
0.19% |
-13,526,000 |
0 |
10.354 |
N/A |
|
MBX |
Mbx Biosciences, Inc. |
63 |
- |
$0.00 |
$11,154,000 |
1,511,334 |
0.19% |
-16,700,000 |
0 |
4.522 |
N/A |
|
BCYC |
Bicycle Therapeutics Ltd |
64 |
- |
$0.00 |
$9,284,000 |
1,093,477 |
0.16% |
-6,025,000 |
0 |
1.585 |
N/A |
|
RCUS |
Arcus Biosciences Inc |
65 |
New |
$7.95 |
$8,920,000 |
1,136,364 |
0.15% |
8,920,000 |
1,136,364 |
1.75 |
N/A |
|
SRZN |
Surrozen Ord Shs |
66 |
- |
$0.50 |
$7,919,000 |
679,130 |
0.13% |
3,864,000 |
396,550 |
1.939 |
N/A |
|
IMTX |
Immatics N.V |
67 |
- |
$5.43 |
$7,893,000 |
1,750,000 |
0.13% |
-4,550,000 |
0 |
1.697 |
N/A |
|
AVTX |
Avalo Therapeutics, Inc |
68 |
- |
$0.43 |
$7,746,000 |
967,000 |
0.13% |
561,000 |
0 |
0.861 |
N/A |
|
PCSC |
Perceptive Capital Solution... |
69 |
- |
$0.00 |
$7,725,000 |
750,000 |
0.13% |
90,000 |
0 |
8.417 |
N/A |
|
DRUG |
Bright Minds Biosciences Or... |
70 |
- |
$0.00 |
$7,446,000 |
206,427 |
0.12% |
-9,153,000 |
-254,402 |
2.294 |
N/A |
|
ACRS |
Aclaris Therapeutics, Inc. |
71 |
- |
$1.47 |
$7,140,000 |
4,666,667 |
0.12% |
-4,433,000 |
0 |
6.303 |
N/A |
|
ACHC |
Acadia Healthcare Company Inc |
72 |
New |
$73.18 |
$6,579,000 |
217,000 |
0.11% |
6,579,000 |
217,000 |
0.219 |
N/A |
|
BBNX |
Beta Bionics, Inc. |
73 |
New |
$15.07 |
$6,120,000 |
500,000 |
0.1% |
6,120,000 |
500,000 |
1.153 |
N/A |
|
XNCR |
Xencor Inc |
74 |
- |
$8.14 |
$6,118,000 |
575,000 |
0.1% |
-7,096,000 |
0 |
0.639 |
Biotechnology |
|
HOWL |
Werewolf Therapeutics, Inc. |
75 |
- |
$0.00 |
$5,974,000 |
6,144,881 |
0.1% |
-3,120,000 |
0 |
15.113 |
N/A |
|
ACET |
Adicet Bio, Inc |
76 |
- |
$0.63 |
$5,693,000 |
7,541,000 |
0.1% |
-1,561,000 |
0 |
9.152 |
N/A |
|
HUMA |
Humacyte, Inc |
77 |
New |
$2.12 |
$5,648,000 |
3,312,356 |
0.09% |
5,648,000 |
3,312,356 |
3.216 |
N/A |
|
ZURA |
Zura Bio Ltd |
78 |
- |
$1.05 |
$4,151,000 |
3,217,503 |
0.07% |
-3,893,000 |
0 |
5.09 |
N/A |
|
BIOA |
Bioage Labs, Inc. |
79 |
- |
$4.20 |
$3,957,000 |
1,052,494 |
0.07% |
-3,631,000 |
-258,095 |
2.938 |
N/A |
|
BOLD |
Boundless Bio, Inc. |
80 |
- |
$1.01 |
$3,293,000 |
2,180,631 |
0.05% |
-3,031,000 |
0 |
9.805 |
N/A |
|
STRO |
Sutro Biopharma Inc |
81 |
New |
$0.73 |
$2,885,000 |
4,434,637 |
0.05% |
2,885,000 |
4,434,637 |
5.411 |
N/A |
|
LXEO |
Lexeo Therapeutics, Inc. |
82 |
- |
$0.00 |
$1,897,000 |
546,554 |
0.03% |
-1,699,000 |
0 |
0 |
N/A |
|
CTMX |
Cytomx Therapeutics, Inc. |
83 |
New |
$0.00 |
$636,000 |
1,000,000 |
0.01% |
636,000 |
1,000,000 |
1.535 |
N/A |
|
SCLX |
Scilex Holding Co |
84 |
- |
$0.00 |
$258,000 |
1,036,218 |
0% |
-184,000 |
0 |
0.732 |
N/A |
|
ALLK |
Allakos Inc. |
93 |
Closed |
$0.33 |
$0 |
0 |
0% |
-1,367,000 |
-1,129,931 |
0 |
N/A |
|
EVH |
Evolent Health, Inc. |
99 |
Closed |
$11.16 |
$0 |
0 |
0% |
-40,243,000 |
-3,577,197 |
0 |
N/A |
|
CCCC |
C4 Therapeutics, Inc. |
85 |
Closed |
$0.00 |
$0 |
0 |
0% |
-17,561,000 |
-4,878,000 |
0 |
N/A |
|
RXRX |
Recursion Pharmaceuticals, ... |
98 |
Closed |
$5.03 |
$0 |
0 |
0% |
-52,222,000 |
-7,725,096 |
0 |
N/A |
|
ENTA |
Enanta Pharmaceuticals Inc |
92 |
Closed |
$7.50 |
$0 |
0 |
0% |
-5,969,000 |
-1,038,000 |
0 |
Biotechnology |
|
PRAX |
Praxis Precision Medicines,... |
97 |
Closed |
$0.00 |
$0 |
0 |
0% |
-58,640,000 |
-761,955 |
0 |
N/A |
|
XBI |
streetTRACKS Series Trust S... |
91 |
Closed |
$83.01 |
$0 |
0 |
0% |
-110,615,000 |
-1,228,240 |
0 |
Closed - End Fund - E... |
|
ARVN |
Arvinas Holding Company, Llc |
96 |
Closed |
$7.54 |
$0 |
0 |
0% |
-8,077,000 |
-421,348 |
0 |
N/A |
|
AXSM |
Axsome Therapeutics, Inc. |
88 |
Closed |
$103.36 |
$0 |
0 |
0% |
-84,610,000 |
-1,000,000 |
0 |
N/A |
|
LEGN |
Churchill Cap Corp Iii |
95 |
Closed |
$34.63 |
$0 |
0 |
0% |
-244,276,000 |
-7,506,934 |
0 |
N/A |
|
RGLS |
Regulus Therapeutics Inc. |
90 |
Closed |
$8.16 |
$0 |
0 |
0% |
-532,000 |
-336,843 |
0 |
Biotechnology |
|
PLRX |
Pliant Therapeutics, Inc. |
87 |
Closed |
$0.00 |
$0 |
0 |
0% |
-16,871,000 |
-1,281,000 |
0 |
N/A |
|
CMRX |
Chimerix Inc |
94 |
Closed |
$8.54 |
$0 |
0 |
0% |
-30,624,000 |
-8,800,000 |
0 |
Biotechnology |
|
VRNA |
Verona Pharma Plc |
89 |
Closed |
$0.00 |
$0 |
0 |
0% |
-82,052,000 |
-1,766,830 |
0 |
N/A |
|
THRD |
Third Harmonic Bio, Inc. |
86 |
Closed |
$5.43 |
$0 |
0 |
0% |
-9,885,000 |
-960,620 |
0 |
N/A |
|